Interdisciplinary Bioengineering Training in Diabetes Research

Information

  • Research Project
  • 10251893
  • ApplicationId
    10251893
  • Core Project Number
    T32DK101001
  • Full Project Number
    5T32DK101001-09
  • Serial Number
    101001
  • FOA Number
    PA-16-152
  • Sub Project Id
  • Project Start Date
    9/4/2013 - 12 years ago
  • Project End Date
    9/3/2023 - 2 years ago
  • Program Officer Name
    CASTLE, ARTHUR
  • Budget Start Date
    9/4/2021 - 4 years ago
  • Budget End Date
    9/3/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    09
  • Suffix
  • Award Notice Date
    9/2/2021 - 4 years ago
Organizations

Interdisciplinary Bioengineering Training in Diabetes Research

PROJECT ABSTRACT Diabetes is a debilitating and burdensome public health problem, affecting an estimated 29.1 million men, women, and children (9.3% of total population) in the U.S. alone. Patients with this and other related metabolic disorders are burdened with devastating quality of life and health consequences, making the need for proper disease management paramount. As a result, there is an urgent demand for transformative technologies that provide both physicians and patients with more options to prevent, diagnose, treat, and cure diabetes, metabolic diseases, and their complications. Furthermore, an interdisciplinary workforce is needed to accelerate development and delivery of these cutting-edge technologies to the clinic and market. The Bioengineering Interdisciplinary Training in Diabetes Research (BTDR) Program, which was initiated in 2013, was strategically designed to meet this need. A notable aspect of the program is that it integrates the strength in engineering education and technology development found at Purdue with excellence in diabetes research found at Indiana University School of Medicine, yielding an uncommon cross-fertilization. The mission of the BTDR program is to develop the next-generation interdisciplinary workforce that innovates, designs, and translates bioengineering technologies to advance the mechanistic understanding, prevention, and treatment of diabetes and its complications. The aims of the BTDR program are to: 1) recruit highly talented students in engineering, physical sciences, computational sciences, analytical chemistry, pharmacology, physiology, and endocrinology with strong research backgrounds and commitment to innovative technology development and diabetes related research; 2) ensure that the next generation of interdisciplinary educators, scientists, policy makers, and physicians includes individuals from diverse ethnic, social, economic, and regional backgrounds, maximizing the scope and breadth of societal impact; and 3) engage students in a novel training experience that integrates basic research, innovation, design, entrepreneurship, and translation, along with vertical mentoring, to develop an integrated workforce that is equipped to accelerate advanced diagnostics and therapeutics to market. The proposed training program provides training pathways for six predoctoral students (two years support per student) from various engineering, physical science, and medical science disciplines, culminating in PHD or MD-PHD degrees. BTDR offers an uncommon interdisciplinary curriculum and rigorous hands-on training focused on technology design and translation guided by faculty with expertise in the cross- cutting areas of Therapeutic Cell & Drug Delivery, Biosensing & Biomaging, Informatics & Modeling, and Molecular Mechanisms & Drug Targets. Trainee outcomes include the ability to operate beyond hypothesis- driven research, incorporating principles of engineering design, standardization and validation, regulatory policy, technology translation, and entrepreneurship.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    T32
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
    165155
  • Indirect Cost Amount
    9932
  • Total Cost
    169598
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIDDK:169598\
  • Funding Mechanism
    TRAINING, INSTITUTIONAL
  • Study Section
    DDK
  • Study Section Name
    Kidney, Urologic and Hematologic Diseases D Subcommittee
  • Organization Name
    PURDUE UNIVERSITY
  • Organization Department
    ENGINEERING (ALL TYPES)
  • Organization DUNS
    072051394
  • Organization City
    WEST LAFAYETTE
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    479072114
  • Organization District
    UNITED STATES